McEnerney J K, Wong W P, Peyman G A
Am J Ophthalmol. 1977 Dec;84(6):847-50. doi: 10.1016/0002-9394(77)90508-6.
Pregnant rabbits in their first and second "trimesters" of gestation were used in a controlled study to evaluate the teratogenicity of fluorescein sodium. Injections of the drug were given in doses comparable to those planned for human administration. No abortions or defects apparent at birth or as delayed manifestations were evident as a result of the drug therapy.
在一项对照研究中，使用处于妊娠前两个月和第二个月的怀孕兔子来评估荧光素钠的致畸性。给予兔子的药物注射剂量与计划用于人体的剂量相当。药物治疗并未导致任何流产或出生时明显的缺陷，也没有出现延迟表现。
